EIR Sovereign Pharmaceuticals Dec 2018

Patty Kaewussdangkul FDA$595.00 - Available Now

FDA investigators audited the Sovereign Pharmaceuticals - Fort Worth, TX, United States facility and issued inspectional observation (via FDA 483) on 19 Dec 2018.

Product details

  • Category:
  • Inspection end: 19 Dec 2018
  • Location: Fort Worth, United States
  • FEI: 3003229412
Add To Cart